Evidence map›Paper›PMID 19028780›Full record

Trial reportEuropean heart journal2009

Lack of benefit from percutaneous intervention of persistently occluded infarct arteries after the acute phase of myocardial infarction is time independent: insights from Occluded Artery Trial.

Venu Menon, Camille A Pearte, Christopher E Buller, Ph Gabriel Steg, Sandra A Forman, Harvey D White, Paolo N Marino, Demosthenes G Katritsis, Paulo Caramori, Ricardo Lasevitch and 4 more

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in European heart journal, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00004562 (Occluded Artery Trial), which is not on this map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00004562 phase3completednot on this map

Occluded Artery Trial (OAT) - Randomized Comparative Effectiveness Trial of PCI and Medical Therapy Only Post MI

TypeinterventionalSponsorNYU Langone HealthRan1999 to 2011Enrolled2,201ConditionsCardiovascular Diseases, Heart Diseases, Myocardial Infarction, Heart Failure, CongestiveArmsBeta adrenergic blockers, Platelet inhibitors, PTCA and stents, ACE Inhibitors
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Trial
  3. Trial
  4. Observational
  5. Review
  6. Article
  7. Management of ST Elevation Myocardial Infarction (STEMI) in Different Settings.The International journal of angiology : official publication of the International College of Angiology, Inc · 2021
    Review
  8. Management of a patient presenting with anterior STEMI with concomitant COVID-19 infection early in the course of the U.S. pandemic.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Venu MenonDivision of Cardiology, F-15, 9500 Euclid Avenue, Cleveland Clinic, Cleveland, OH 4419, USA.
Camille A Pearte
Christopher E Buller
Ph Gabriel Steg
Sandra A Forman
Harvey D White
Paolo N Marino
Demosthenes G Katritsis
Paulo Caramori
Ricardo Lasevitch
Krystyna Loboz-Grudzien
Aleksander Zurakowski
Gervasio A Lamas
Judith S Hochman

Funding

Occluded Artery Trial: Long Term Follow-UpU01HL062509 · NHLBI · ST. LUKE'S-ROOSEVELT INST FOR HLTH SCIS · PI HOCHMAN, JUDITH S · 1999 to 2010
$11.1M
Occluded Artery Trial: Long-Term Follow up-Data Coordinating CenterU01HL062511 · NHLBI · MARYLAND MEDICAL RESEARCH INSTITUTE, INC · PI FORMAN, SANDRA · 1999 to 2010
$5.2M
NHLBI NIH HHS U01 HL062509NHLBI NIH HHS U01 HL062511
6 · The paper itself

Abstract

aimsThe Occluded Artery Trial (OAT) (n = 2201) showed no benefit for routine percutaneous intervention (PCI) (n = 1101) over medical therapy (MED) (n = 1100) on the combined endpoint of death, myocardial infarction (MI), and class IV heart failure (congestive heart failure) in stable post-MI patients with late occluded infarct-related arteries (IRAs). We evaluated the potential for selective benefit with PCI over MED for patients enrolled early in OAT. METHODS AND

resultsWe explored outcomes with PCI over MED in patients randomized to the </=3 calendar days and </=7 calendar days post-MI time windows. Earlier, times to randomization in OAT were associated with higher rates of the combined endpoint (adjusted HR 1.04/day: 99% CI 1.01-1.06; P < 0.001). The 48-month event rates for </=3 days, </=7 days post-MI enrolled patients were similar for PCI vs. MED for the combined and individual endpoints. There was no interaction between time to randomization defined as a continuous (P = 0.55) or categorical variable with a cut-point of 3 days (P = 0.98) or 7 days (P = 0.64) post-MI and treatment effect.

conclusionConsistent with overall OAT findings, patients enrolled in the </=3 day and </=7 day post-MI time windows derived no benefit with PCI over MED with no interaction between time to randomization and treatment effect. Our findings do not support routine PCI of the occluded IRA in trial-eligible patients even in the earliest 24-72 h time window.

Indexed as

Angioplasty, Balloon, CoronaryAgedCoronary DiseaseFemaleHumansMaleMiddle AgedMyocardial InfarctionTime FactorsTreatment Outcome

Identifiers

PMID19028780
PMCPMC2639108

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.